Clinical Trials
2 trialsNCT05815927 2026-05-28
PROLoNg
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Recruiting
NCT05096663 2026-05-18
Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
SWOG Cancer Research Network
Phase 2/3 Active not recruiting